Keiichiro Yoshioka

529 total citations
37 papers, 398 citations indexed

About

Keiichiro Yoshioka is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Epidemiology. According to data from OpenAlex, Keiichiro Yoshioka has authored 37 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Hematology and 8 papers in Epidemiology. Recurrent topics in Keiichiro Yoshioka's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Hepatitis C virus research (5 papers) and Platelet Disorders and Treatments (4 papers). Keiichiro Yoshioka is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Hepatitis C virus research (5 papers) and Platelet Disorders and Treatments (4 papers). Keiichiro Yoshioka collaborates with scholars based in Japan and United States. Keiichiro Yoshioka's co-authors include Seiji Kinoshita, Koichiro Tatsumi, S Kinoshita, Mitsuhiro Abe, Mari Amino, Shinichi Kakumu, Akira Yoshioka, Yoshiya Furusawa, Osamu Takamiya and Wojciech Zaręba and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Keiichiro Yoshioka

36 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichiro Yoshioka Japan 12 108 91 83 76 65 37 398
César Jiménez Spain 8 71 0.7× 37 0.4× 23 0.3× 32 0.4× 53 0.8× 25 368
L Moriconi Italy 12 77 0.7× 40 0.4× 187 2.3× 100 1.3× 13 0.2× 37 452
Gianna Mazzucco Italy 7 45 0.4× 23 0.3× 110 1.3× 61 0.8× 16 0.2× 12 381
L. de Rossi Germany 10 136 1.3× 34 0.4× 33 0.4× 35 0.5× 59 0.9× 18 417
George Wadih United States 9 75 0.7× 72 0.8× 19 0.2× 51 0.7× 25 0.4× 11 555
Eri Miyata Japan 10 35 0.3× 68 0.7× 48 0.6× 42 0.6× 35 0.5× 37 327
Maria Leontsini Greece 13 87 0.8× 21 0.2× 36 0.4× 61 0.8× 14 0.2× 28 488
Christopher Burghuber Austria 14 50 0.5× 41 0.5× 114 1.4× 82 1.1× 23 0.4× 26 614
KY Wong China 12 43 0.4× 32 0.4× 29 0.3× 43 0.6× 22 0.3× 24 383
Bogdan Obrișcă Romania 12 68 0.6× 63 0.7× 28 0.3× 32 0.4× 18 0.3× 52 409

Countries citing papers authored by Keiichiro Yoshioka

Since Specialization
Citations

This map shows the geographic impact of Keiichiro Yoshioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichiro Yoshioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichiro Yoshioka more than expected).

Fields of papers citing papers by Keiichiro Yoshioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichiro Yoshioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichiro Yoshioka. The network helps show where Keiichiro Yoshioka may publish in the future.

Co-authorship network of co-authors of Keiichiro Yoshioka

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichiro Yoshioka. A scholar is included among the top collaborators of Keiichiro Yoshioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichiro Yoshioka. Keiichiro Yoshioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawasaki, Takeshi, Hironori Sato, Koichiro Tatsumi, et al.. (2024). Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 25(7). 3750–3750. 4 indexed citations
2.
Yoshioka, Keiichiro, et al.. (2023). Upper Airway Simulation of Obstructive Sleep Apnea Syndrome. Advanced Biomedical Engineering. 12(0). 74–80. 1 indexed citations
3.
Kawasaki, Takeshi, Hironori Sato, Koichiro Tatsumi, et al.. (2023). Different Transcriptome Features of Peripheral Blood Mononuclear Cells in Non-Emphysematous Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences. 25(1). 66–66. 6 indexed citations
4.
Yoshioka, Keiichiro, Hironori Sato, Takeshi Kawasaki, et al.. (2022). Transcriptome Analysis of Peripheral Blood Mononuclear Cells in Pulmonary Sarcoidosis. Frontiers in Medicine. 9. 822094–822094. 12 indexed citations
5.
Nakada, Taka‐aki, Takashi Shimazui, Mitsuhiro Abe, et al.. (2021). Prognostic value of lymphocyte counts in bronchoalveolar lavage fluid in patients with acute respiratory failure: a retrospective cohort study. Journal of Intensive Care. 9(1). 21–21. 7 indexed citations
6.
Abe, Mitsuhiro, Yuki Shiko, Kenji Tsushima, et al.. (2021). What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?. The Clinical Respiratory Journal. 16(2). 142–151. 6 indexed citations
7.
Abe, Mitsuhiro, Kenji Tsushima, Daisuke Ishii, et al.. (2021). Risk Factors for Acute Exacerbation Following Bronchoalveolar Lavage in Patients with Suspected Idiopathic Pulmonary Fibrosis: A Retrospective Cohort Study. Advances in respiratory medicine. 89(2). 101–109. 5 indexed citations
8.
Yoshioka, Keiichiro, et al.. (2021). Exacerbation of autoimmune pulmonary alveolar proteinosis that improved with lone treatment of complicating nontuberculous mycobacterial infection: A case report. Respiratory Medicine Case Reports. 34. 101521–101521. 3 indexed citations
9.
Abe, Mitsuhiro, Kenji Tsushima, Keiichiro Yoshioka, et al.. (2020). The Gender–Age–Physiology System as a Prognostic Model in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib: A Longitudinal Cohort Study. Advances in respiratory medicine. 88(5). 369–376. 3 indexed citations
10.
Murthi, Mukunthan, Keiichiro Yoshioka, Sixto Arias, et al.. (2020). Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study. ERJ Open Research. 6(4). 61–2020. 18 indexed citations
11.
Terada, Jiro, Mitsuhiro Abe, Kenichi Suzuki, et al.. (2019). <p>Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis</p>. Drug Design Development and Therapy. Volume 13. 2295–2303. 11 indexed citations
12.
Morita, Seiji, Jun Koizumi, Kasumi Sakurai, et al.. (2009). Atypical extravasation of contrast medium in massive extrapleural haematoma due to cardiac massage without rib fracture. Emergency Medicine Journal. 26(10). 710–710. 3 indexed citations
13.
Amino, Mari, Keiichiro Yoshioka, T. Tanabe, et al.. (2006). Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction. Cardiovascular Research. 72(3). 412–421. 74 indexed citations
14.
Yoshioka, Keiichiro, Hiroshi Ito, K. Watanabe, et al.. (2005). Interferon sensitivity‐determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection. Journal of Viral Hepatitis. 12(2). 139–145. 5 indexed citations
15.
16.
Kinoshita, Seiji, et al.. (1991). Acquired von Willebrand disease after Epstein-Barr virus infection. The Journal of Pediatrics. 119(4). 595–598. 23 indexed citations
17.
Kakumu, Shinichi, et al.. (1990). Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis.. PubMed. 33(1). 1–6. 6 indexed citations
18.
Fujimura, Yoshihiro, et al.. (1982). Studies on Vitamin K-Dependent Factor Deficiency during Early Childhood with Special Reference to Prothrombin Activity and Antigen Level. Pathophysiology of Haemostasis and Thrombosis. 11(2). 90–95. 7 indexed citations
19.
Ishida, Yoji, Shiro Miwa, Kazuaki Miyake, et al.. (1981). Clinical and Biochemical Studies. 22(3). 306–316. 13 indexed citations
20.
Kobayashi, Shiro, et al.. (1974). Entstehungsmechanismus von L-Asparaginase-Nebenwirkungen und deren Bekämpfung. Annals of Hematology. 28(1). 43–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by César Jiménez Breakdown of academic impact, for papers by L Moriconi Breakdown of academic impact, for papers by Gianna Mazzucco Breakdown of academic impact, for papers by L. de Rossi Breakdown of academic impact, for papers by George Wadih Breakdown of academic impact, for papers by Eri Miyata Breakdown of academic impact, for papers by Maria Leontsini Breakdown of academic impact, for papers by Christopher Burghuber Breakdown of academic impact, for papers by KY Wong Breakdown of academic impact, for papers by Bogdan Obrișcă
Rankless by CCL
2026